Breaking News Instant updates and real-time market news.

2021-02-24 12:50:34 HSII Heidrick & Struggles $37.36 / +1.08 (+2.98%) 12:50 02/24/21 02/24 12:50 02/24/21 12:50	Barrington upgrades Heidrick & Struggles to Outperform, sees continued recovery As previously reported, Barrington analyst Kevin Steinke upgraded Heidrick & Struggles to Outperform from Market Perform with a $42 price target following the company's Q4 revenue and EBITDA beat and Q1 guidance that he said point to a "continued recovery." He is encouraged by the speed at which revenue has rebounded from pandemic lows along with the company's ability to gain market share, Steinke tells investors in a post-earnings research note.
HSII Heidrick & Struggles $37.36 / +1.08 (+2.98%) 02/24/21 Barrington Heidrick & Struggles upgraded to Outperform from Market Perform at Barrington 02/23/21 Truist Heidrick & Struggles price target raised to $40 from $25 at Truist 04/29/20 Barrington Heidrick & Struggles downgraded to Market Perform from Outperform at Barrington

2021-02-24 12:50:34

HSII

Heidrick & Struggles

$37.36 / +1.08 (+2.98%)

12:50

02/24/21

02/24

12:50

02/24/21

12:50

Barrington upgrades Heidrick & Struggles to Outperform, sees continued recovery

As previously reported, Barrington analyst Kevin Steinke upgraded Heidrick & Struggles to Outperform from Market Perform with a $42 price target following the company's Q4 revenue and EBITDA beat and Q1 guidance that he said point to a "continued recovery." He is encouraged by the speed at which revenue has rebounded from pandemic lows along with the company's ability to gain market share, Steinke tells investors in a post-earnings research note.

HSII Heidrick & Struggles

$37.36 / +1.08 (+2.98%)

02/24/21 Barrington: Heidrick & Struggles upgraded to Outperform from Market Perform at Barrington

02/23/21 Truist: Heidrick & Struggles price target raised to $40 from $25 at Truist

04/29/20 Barrington: Heidrick & Struggles downgraded to Market Perform from Outperform at Barrington

TODAY'S FREE FLY STORIES

Upgrade	Jefferies upgrades Evelo Biosciences to Buy on increased microbiome momentum » 07:52 04/12/21 04/12 07:52 04/12/21 07:52 EVLO Evelo Biosciences $10.03 / +0.005 (+0.05%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events Options EVLO Evelo Biosciences $10.03 / +0.005 (+0.05%) 03/23/21 Evelo Biosciences announces collaboration with Abdul Latif Jameel Health 03/09/21 Evelo Biosciences announces data from experimental model with EDP1815 03/09/21 Evelo Biosciences announces expected 2021 milestones 02/16/21 Evelo Biosciences appoints John Hohneker to board of directors EVLO Evelo Biosciences $10.03 / +0.005 (+0.05%) 04:50 Today Jefferies Evelo Biosciences upgraded to Buy from Hold at Jefferies 03/12/21 Chardan Evelo Biosciences price target raised to $15 from $10 at Chardan 01/25/21 JMP Securities Evelo Biosciences price target raised to $36 from $27 at JMP Securities 12/30/20 JMP Securities Evelo shares undervalued into atopic dermatitis data, says JMP Securities EVLO Evelo Biosciences $10.03 / +0.005 (+0.05%) 03/09/21 Evelo Biosciences reports Q4 EPS (62c), consensus (53c) 10/29/20 Evelo Biosciences reports Q3 EPS (45c), consensus (50c) 29 Jan 25 Jun 00:00 Today 20th Annual Virtual Healthcare Virtual Conference EVLO Evelo Biosciences $10.03 / +0.005 (+0.05%) 02/03/21 new option listings on February 3rd
Initiation	Duckhorn Portfolio initiated with a Buy at Jefferies » 07:48 04/12/21 04/12 07:48 04/12/21 07:48 NAPA Duckhorn Portfolio $18.89 / +0.785 (+4.34%) Jefferies analyst Kevin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Syndicate On The Fly Options NAPA Duckhorn Portfolio $18.89 / +0.785 (+4.34%) 07:19 Today JPMorgan Duckhorn Portfolio initiated with an Overweight at JPMorgan 06:48 Today Citi Duckhorn Portfolio initiated with a Buy at Citi 06:44 Today Evercore ISI Duckhorn Portfolio initiated with an Outperform at Evercore ISI 06:24 Today Credit Suisse Duckhorn Portfolio initiated with an Outperform at Credit Suisse 18 Mar NAPA Duckhorn Portfolio $18.89 / +0.785 (+4.34%) 03/20/21 Opening Day: China's Tuya raised $915M in U.S. IPO NAPA Duckhorn Portfolio $18.89 / +0.785 (+4.34%) 04/07/21 new option listings and two option delistings on April 7th
Hot Stocks	Jazz Pharmaceuticals: FDA grants Priority Review of sNDA for Xywav » 07:48 04/12/21 04/12 07:48 04/12/21 07:48 JAZZ Jazz Pharmaceuticals $161.34 / +0.43 (+0.27%) Jazz Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events JAZZ Jazz Pharmaceuticals $161.34 / +0.43 (+0.27%) 04/01/21 Lava Therapeutics appoints Karen Wilson to board of directors 03/30/21 Jazz announces FDA approved revised label for Vyxeos 02/16/21 Jazz completes rolling submission for sNDA to FDA for Xywav oral solution 02/03/21 Jazz, GW Pharmaceuticals combo expected to accretive in first full year JAZZ Jazz Pharmaceuticals $161.34 / +0.43 (+0.27%) 04/06/21 RBC Capital Jazz Pharmaceuticals transferred with an Outperform at RBC Capital 04/01/21 Morgan Stanley Jazz Pharmaceuticals price target raised to $176 from $162 at Morgan Stanley 03/01/21 UBS Jazz Pharmaceuticals price target raised to $228 from $174 at UBS 02/24/21 Cowen Jazz Pharmaceuticals price target raised to $200 from $190 at Cowen JAZZ Jazz Pharmaceuticals $161.34 / +0.43 (+0.27%) 02/23/21 Jazz Pharmaceuticals sees FY21 adjusted EPS $15.65-$16.85, consensus $16.78 02/23/21 Jazz Pharmaceuticals reports Q4 EPS $4.00, consensus $4.20 02/16/21 GW Pharmaceuticals reports Q4 EPS (8c), consensus (60c) 11/02/20 Jazz Pharma narrows FY20 non-GAAP EPS view to $12.20-$13.00 from $11.90-$13.00 JAZZ Jazz Pharmaceuticals $161.34 / +0.43 (+0.27%) 04/05/21 'Failure is the new winning' for Jazz Pharmaceuticals, FFJ says JAZZ Jazz Pharmaceuticals $161.34 / +0.43 (+0.27%) 02/18/21 Rising High: An exclusive talk with multinational cannabis company Clever Leaves 02/11/21 Rising High: An exclusive talk with biotech company Enveric Biosciences 02/03/21 Fly Intel: Wall Street's top stories for Wednesday 02/03/21 Fly Intel: Wall Street's top stories at midday 05/24/21 Global Healthcare Virtual Conference 2021
Hot Stocks	Beyond Meat announces product distribution expansion with European retailers » 07:48 04/12/21 04/12 07:48 04/12/21 07:48 BYND Beyond Meat $130.24 / -4.45 (-3.30%) Beyond Meat announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BYND Beyond Meat $130.24 / -4.45 (-3.30%) 04/08/21 Beyond Meat expands U.S. retail distribution within multiple grocery chains 04/07/21 Beyond Meat opens new manufacturing facility in JXEDZ near Shanghai 03/09/21 Walmart to expand Beyond Meat product offerings at stores 03/03/21 Peet's Coffee, Beyond Meat, JUST Egg launch 'Everything Plant-Based Sandwich' BYND Beyond Meat $130.24 / -4.45 (-3.30%) 04/07/21 Piper Sandler Piper Sandler survey shows more teens open to plant-based meat 04/05/21 JPMorgan BellRing, Hostess among JPMorgan's 'Own Now' names in food 03/19/21 Fly Intel: Top five analyst initiations 03/18/21 Stephens Stephens starts Beyond Meat at buy with alternative protein 'going mainstream' BYND Beyond Meat $130.24 / -4.45 (-3.30%) 02/25/21 Beyond Meat reports Q4 adjusted EPS (34c), consensus (13c) 02/25/21 Notable companies reporting after market close 11/09/20 Beyond Meat reports Q3 adj. EPS (28c), consensus 5c 11/09/20 Notable companies reporting after market close BYND Beyond Meat $130.24 / -4.45 (-3.30%) 04/08/21 Impossible Foods preparing for public listing, Reuters reports 04/08/21 Beyond Meat rival Impossible Foods prepping to come public, Reuters says 02/26/21 McDonald's clarifies to Bloomberg Beyond Meat's 'preferred supplier' status 02/04/21 Lawsuit challenging FDA approval of Impossible color additive, FSN reports BYND Beyond Meat $130.24 / -4.45 (-3.30%) 04/11/21 On the Fly: The Week in SPAC News 03/19/21 Molson Coors downgrade, Starbucks upgrade among today's top calls on Wall Street 03/02/21 Citi says buy Beyond Meat, has 'new-found enthusiasm' following partnerships 03/01/21 Fly Intel: After-Hours Movers BYND Beyond Meat $130.24 / -4.45 (-3.30%) 04/08/21 Unusually active option classes on open April 8th 04/07/21 Unusually active option classes on open April 7th 03/02/21 Unusually active option classes on open March 2nd 03/02/21 Largest borrow rate increases among liquid names
Earnings	InMode sees Q1 adjusted EPS 65c-67c, consensus 46c » 07:46 04/12/21 04/12 07:46 04/12/21 07:46 INMD InMode $80.64 / -0.19 (-0.24%) Sees Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options INMD InMode $80.64 / -0.19 (-0.24%) 03/16/21 InMode files complaint against Cutera with the U.S. ITC 11/11/20 InMode granted U.S. patent for fractional radiofrequency technology Morpues8 INMD InMode $80.64 / -0.19 (-0.24%) 02/11/21 Baird InMode price target raised to $84 from $58 at Baird 02/11/21 Canaccord InMode price target raised to $80 from $69 at Canaccord 02/11/21 UBS InMode price target raised to $84 from $64 at UBS 10/21/20 Canaccord InMode price target raised to $51 from $42 at Canaccord INMD InMode $80.64 / -0.19 (-0.24%) 02/10/21 InMode sees 2021 non-GAAP EPS $2.34-$2.45, consensus $2.19 02/10/21 InMode reports Q4 non-GAAP EPS 94c, consensus 75c 01/12/21 InMode sees FY21 revenue $250M-$260M, consensus $245.08M 01/12/21 InMode sees FY20 non-GAAP EPS $2.08-$2.10, consensus $1.79 00:00 Today 20th Annual Virtual Healthcare Virtual Conference 05/24/21 Global Healthcare Virtual Conference 2021 INMD InMode $80.64 / -0.19 (-0.24%) 03/22/21 Largest borrow rate increases among liquid names 02/22/21 Largest borrow rate increases among liquid names 12/30/20 Largest borrow rate increases among liquid names 12/29/20 Largest borrow rate increases among liquid names

Hot Stocks	Centerra Gold to list common shares on NYSE » 07:45 04/12/21 04/12 07:45 04/12/21 07:45 CGAU Centerra Gold / + Centerra Gold is pleased… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Recommendations	PROG Holdings price target lowered to $58 from $65 at Truist » 07:45 04/12/21 04/12 07:45 04/12/21 07:45 PRG PROG Holdings $43.93 / +0.5 (+1.15%) Truist analyst Bill… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options PRG PROG Holdings $43.93 / +0.5 (+1.15%) 12/01/20 PROG Holdings begins operating as independent, publicly traded company PRG PROG Holdings $43.93 / +0.5 (+1.15%) 02/24/21 Stephens Aaron's peers also potentially received California inquiry, says Stephens 12/22/20 Raymond James Rent-A-Center price target raised to $45 from $38 at Raymond James 12/22/20 Stephens Rent-A-Center price target raised to $52 from $45 at Stephens 12/14/20 Berenberg Aaron's initiated with a Buy at Berenberg PRG PROG Holdings $43.93 / +0.5 (+1.15%) 02/25/21 PROG Holdings reports Q4 non-GAAP EPS 95c, consensus 90c 04/29/21 PROG Holdings - PRG PRG PROG Holdings $43.93 / +0.5 (+1.15%) 12/01/20 Two new option listings and two option delistings on December 1st
Hot Stocks	Cytokinetics announces preclinical data for CK-3773274 » 07:45 04/12/21 04/12 07:45 04/12/21 07:45 CYTK Cytokinetics $24.17 / +0.01 (+0.04%) Cytokinetics announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events Options CYTK Cytokinetics $24.17 / +0.01 (+0.04%) 02/18/21 Cytokinetics appoints Muna Bhanji to board of directors 01/13/21 Cytokinetics announces dosing of first patient in Cohort 2 of Redwood-HCM 01/11/21 Cytokinetics granted orphan drug designation for CK-3773274 in HCM 12/23/20 Cytokinetics regains European rights to omecamtiv mecarbil CYTK Cytokinetics $24.17 / +0.01 (+0.04%) 03/11/21 Wolfe Research Cytokinetics initiated with an Outperform at Wolfe Research 02/18/21 Barclays Cytokinetics initiated with an Overweight at Barclays 01/20/21 H.C. Wainwright Cytokinetics price target raised to $41 from $22 at H.C. Wainwright 12/28/20 Oppenheimer Amgen price target lowered to $266 from $274 at Oppenheimer CYTK Cytokinetics $24.17 / +0.01 (+0.04%) 11/04/20 Cytokinetics reports Q3 EPS (5c), consensus (34c) 17 Jul 00:00 Today 20th Annual Virtual Healthcare Virtual Conference 05/12/21 Cytokinetics Inc CYTK Cytokinetics $24.17 / +0.01 (+0.04%) 10/29/20 Cytokinetics call volume above normal and directionally bullish
Initiation	Vine Energy initiated with an Overweight at Morgan Stanley » 07:44 04/12/21 04/12 07:44 04/12/21 07:44 VEI Vine Energy $12.11 / +0.11 (+0.92%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Syndicate On The Fly VEI Vine Energy $12.11 / +0.11 (+0.92%) 06:50 Today Citi Vine Energy initiated with a Buy at Citi 06:22 Today Barclays Vine Energy initiated with an Equal Weight at Barclays 06:17 Today RBC Capital Vine Energy initiated with an Outperform at RBC Capital 06:16 Today BofA Vine Energy initiated with a Buy at BofA 18 Mar VEI Vine Energy $12.11 / +0.11 (+0.92%) 03/20/21 Opening Day: China's Tuya raised $915M in U.S. IPO
Hot Stocks	OpGen announces results from webinar on bacterial pneumonia co-infections » 07:42 04/12/21 04/12 07:42 04/12/21 07:42 OPGN OpGen $2.68 / -0.045 (-1.65%) OpGen announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly OPGN OpGen $2.68 / -0.045 (-1.65%) 03/08/21 OpGen announces publication of study results of Unyvero HPN panel 03/01/21 OpGen wins Chinese NMPA approval for Curetis Unyvero System 02/16/21 Ares Genetics announces publication of study on prediction of AST results 01/05/21 OpGen's Curetis, Annar enter Unyvero distribution partnership OPGN OpGen $2.68 / -0.045 (-1.65%) 03/02/21 Alliance Global Partners Alliance Global raises OpGen price target to $7, sees 'eventful 2021' 11/13/20 Alliance Global Partners OpGen price target raised to $5.65 from $5.00 at Alliance Global Partners 06/09/20 Alliance Global Partners Alliance Global Partners sees OpGen preliminary data as positive 06/03/20 Alliance Global Partners OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global OPGN OpGen $2.68 / -0.045 (-1.65%) 01/13/21 OpGen reports preliminary 2020 revenue $5.2M, consensus $4.15M 01/13/21 OpGen reports preliminary Q4 revenue $1.3M, two est. $1.4M 10/15/20 OpGen reports preliminary Q3 revenue approx. $1M, one est. $1.6M OPGN OpGen $2.68 / -0.045 (-1.65%) 03/09/21 Second Sight, Auris Medical soar as 'meme stock' mania continues

Hot Stocks	Intellia Therapeutics appoints Georgia Keresty to board of directors » 07:41 04/12/21 04/12 07:41 04/12/21 07:41 NTLA Intellia Therapeutics $70.54 / -2.33 (-3.20%) , TAK Takeda Pharmaceutical $17.25 / +0.195 (+1.14%) , AZPN Aspen Technology $153.02 / -1.02 (-0.66%) , SLDB Solid Biosciences $5.20 / -0.17 (-3.17%) Intellia Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options NTLA TAK AZPN SLDB NTLA Intellia Therapeutics $70.54 / -2.33 (-3.20%) 03/30/21 Intellia Therapeutics treatment NTLA-2001 receives EU orphan drug designation 03/25/21 Intellia Therapeutics presents new data on expanded cell engineering 03/10/21 Intellia Therapeutics presents preclinical PoC for CRISPR-based in vivo editing 01/07/21 Intellia expects cash to fund requirements for at least next 24 months TAK Takeda Pharmaceutical $17.25 / +0.195 (+1.14%) 04/07/21 Kamada announces amendment to GLASSIA license agreement with Takeda 03/31/21 Takeda Pharmaceutical completes sale of OTC, non-core assets to Orifarm 03/30/21 Ovid Therapeutics, Takeda close agreement for commercialization of soticlestat 03/15/21 Takeda granted orphan status for pouchitis treatment vedolizumab AZPN Aspen Technology $153.02 / -1.02 (-0.66%) 03/17/21 L&T Technology Services and Aspen Technology team on engineering solutions 03/02/21 Aspen Technology appoints Chantelle Breithaupt CFO 03/02/21 Aspen Technology appoints Chantelle Breithaupt CFO 03/02/21 KVH Industries appoints Roger Kuebel as CFO SLDB Solid Biosciences $5.20 / -0.17 (-3.17%) 03/29/21 Suvretta Capital reports 5.13% passive stake in Solid Biosciences 03/15/21 Solid Biosciences reports interim functioning, biomarker data from IGNITE DMD 03/04/21 Solid Biosciences reports inducement grant to new CLO 03/04/21 Solid Biosciences names Erin Powers Brennan CLO, Joel Schneider COO NTLA TAK AZPN SLDB NTLA Intellia Therapeutics $70.54 / -2.33 (-3.20%) 03/04/21 JMP Securities Intellia Therapeutics initiated with an Outperform at JMP Securities 02/26/21 Truist Intellia Therapeutics price target raised to $80 from $40 at Truist 02/10/21 Chardan Intellia Therapeutics price target raised to $85 from $57.50 at Chardan 01/08/21 Barclays Intellia Therapeutics price target raised to $90 from $46 at Barclays TAK Takeda Pharmaceutical $17.25 / +0.195 (+1.14%) 04/05/21 Fly Intel: Top five analyst downgrades 04/05/21 Barclays Molecular Templates MT-3724 discontinuation shouldn't be surprise, says Barclays 04/05/21 Jefferies Takeda Pharmaceutical downgraded to Hold from Buy at Jefferies 03/03/21 RBC Capital Ovid downgraded to Sector Perform at RBC Capital after rally on Takeda deal AZPN Aspen Technology $153.02 / -1.02 (-0.66%) 02/16/21 KeyBanc Aspen Technology price target raised to $180 from $158 at KeyBanc 02/03/21 Baird Aspen Technology upgraded to Outperform from Neutral at Baird 01/05/21 Benchmark GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021 09/23/20 BofA Aspen Technology reinstated with a Neutral at BofA SLDB Solid Biosciences $5.20 / -0.17 (-3.17%) 03/16/21 Chardan Solid Biosciences price target raised to $20 from $12.50 at Chardan 03/16/21 Fly Intel: Top five analyst upgrades 03/16/21 SVB Leerink Solid Biosciences upgraded to Outperform at SVB Leerink 03/16/21 SVB Leerink Solid Biosciences upgraded to Outperform from Market Perform at SVB Leerink NTLA TAK AZPN SLDB NTLA Intellia Therapeutics $70.54 / -2.33 (-3.20%) 11/05/20 Intellia Therapeutics reports Q3 EPS (47c), consensus (59c) TAK Takeda Pharmaceutical $17.25 / +0.195 (+1.14%) 04/05/21 Molecular Templates to assume full rights of TAK-169 from Takeda AZPN Aspen Technology $153.02 / -1.02 (-0.66%) 01/27/21 Aspen Technology sees FY21 adjusted EPS $5.29-$5.58, consensus $5.00 01/27/21 Aspen Technology reports Q2 adjusted EPS $2.04, consensus $1.17 11/05/20 Aspen Technology backs FY21 adjusted EPS view $4.78-$5.32, consensus $5.01 SLDB Solid Biosciences $5.20 / -0.17 (-3.17%) 11/05/20 Solid Biosciences reports Q3 EPS (44c), consensus (34c) 19 Mar 02 Dec 03 Jun NTLA TAK SLDB NTLA Intellia Therapeutics $70.54 / -2.33 (-3.20%) 11/30/20 Fly Intel: After-Hours Movers TAK Takeda Pharmaceutical $17.25 / +0.195 (+1.14%) 03/03/21 Fly Intel: Wall Street's top stories for Wednesday 03/03/21 Fly Intel: Wall Street's top stories at midday 03/03/21 Fly Intel: Pre-market Movers SLDB Solid Biosciences $5.20 / -0.17 (-3.17%) 03/16/21 Fly Intel: Wall Street's top stories for Tuesday 03/16/21 Fly Intel: Wall Street's top stories at midday 12/11/20 Fly Intel: Wall Street's top stories at midday 12/11/20 Fly Intel: Pre-market Movers 05/24/21 Global Technology, Media & Communications Virtual Conference TAK TAK Takeda Pharmaceutical $17.25 / +0.195 (+1.14%) 04/06/21 Largest borrow rate increases among liquid names 04/05/21 Largest borrow rate increases among liquid names 03/19/21 Takeda Pharmaceutical call volume above normal and directionally bullish 03/17/21 Unusually active option classes on open March 17th
Hot Stocks	Platinum Equity to acquire Club Car from Ingersoll Rand for $1.7B » 07:40 04/12/21 04/12 07:40 04/12/21 07:40 IR Ingersoll-Rand $50.59 / +0.255 (+0.51%) Platinum Equity announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals Events IR Ingersoll-Rand $50.59 / +0.255 (+0.51%) 07:37 Today Ingersoll-Rand to sell specialty vehicle technologies segment to Platinum Equity 02/18/21 Ingersoll Rand selects Google Cloud to accelerate IoT innovation 02/16/21 AIP to acquire majority interest in Ingersoll-Rand's HPS segment 02/16/21 Ingersoll-Rand to sell majority interest in HPS to American Industrial Partners IR Ingersoll-Rand $50.59 / +0.255 (+0.51%) 04/06/21 Barclays Ingersoll-Rand price target raised to $56 from $53 at Barclays 02/24/21 Deutsche Bank Ingersoll-Rand price target raised to $50 from $47 at Deutsche Bank 02/16/21 UBS Ingersoll-Rand's deal to sell HPS interest 'positive,' says UBS 01/15/21 Jefferies Ingersoll-Rand price target raised to $53 from $45 at Jefferies IR Ingersoll-Rand $50.59 / +0.255 (+0.51%) 02/22/21 Ingersoll Rand sees FY21 revenue growth high-single to low-double digits 02/22/21 Ingersoll Rand reports Q4 adjusted EPS 53c, consensus 45c 02/22/21 Notable companies reporting after market close 11/02/20 Ingersoll-Rand reports Q3 adj. EPS 40c, consensus 31c 17 Jun IR Ingersoll-Rand $50.59 / +0.255 (+0.51%) 04/11/21 Ingersoll-Rand nearing $1.7B deal to sell golf cart business, Reuters reports 06/16/21 Ingersoll-Rand Inc
General news	Treasury Market Outlook: U.S. markets are little changed but still slightly underwater » 07:40 04/12/21 04/12 07:40 04/12/21 07:40 $ECON Economic Data / + Treasury Market Outlook:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><<
Recommendations	Southwest price target raised to $71 from $54 at Raymond James » 07:40 04/12/21 04/12 07:40 04/12/21 07:40 LUV Southwest $63.41 / -0.06 (-0.09%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options LUV Southwest $63.41 / -0.06 (-0.09%) 04/05/21 CDC issues updated guidance on travel for fully vaccinated people 03/30/21 Southwest offers pre-cleared arrival into Hawaii 03/29/21 Southwest orders 100 Boeing 737 MAX jets, plus 155 options 03/29/21 Southwest adds 100 firm orders for Boeing 737 MAX 7 LUV Southwest $63.41 / -0.06 (-0.09%) 04/06/21 Morgan Stanley Southwest price target raised to $80 from $59 at Morgan Stanley 03/30/21 Jefferies Southwest price target raised to $70 from $55 at Jefferies 03/23/21 Fly Intel: Top five analyst upgrades 03/23/21 Argus Southwest upgraded to Buy from Hold at Argus LUV Southwest $63.41 / -0.06 (-0.09%) 01/28/21 Southwest reports Q4 ex-items EPS ($1.29), consensus ($1.68) 01/27/21 Notable companies reporting before tomorrow's open 01/27/21 Notable companies reporting before tomorrow's open 11/12/20 Southwest reports October operating revenue down about 65% year-over-year 29 Apr LUV Southwest $63.41 / -0.06 (-0.09%) 04/08/21 Southwest to bring back over 2,700 flight attendants for summer, Reuters says 03/31/21 Delta Air Lines to begin selling all seats on flights starting May 1, CNBC says 03/29/21 CDC chief warns of 'impending doom' amid rise in travel, AP reports 03/18/21 Biden administration looks to ease travel restrictions in mid-May, CNBC says LUV Southwest $63.41 / -0.06 (-0.09%) 03/29/21 Fly Intel: Wall Street's top stories for Monday 03/29/21 Fly Intel: Wall Street's top stories at midday 03/23/21 Netflix, Southwest upgrades among today's top calls on Wall Street 02/22/21 Airbnb, Snap upgrades among today's top calls on Wall Street LUV Southwest $63.41 / -0.06 (-0.09%) 03/08/21 Early notable gainers among liquid option names on March 8th 02/22/21 Southwest put volume heavy and directionally bearish 02/08/21 Southwest call volume above normal and directionally bullish 01/11/21 Unusually active option classes on open January 11th
Hot Stocks	Intra-Cellular announces presentation on PDE1 inhibitor program » 07:39 04/12/21 04/12 07:39 04/12/21 07:39 ITCI Intra-Cellular $31.68 / +0.17 (+0.54%) Intra-Cellular Therapies… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate ITCI Intra-Cellular $31.68 / +0.17 (+0.54%) 02/24/21 Intra-Cellular introduces new molecular entity ITI-1284 02/22/21 Intra-Cellular applies for FDA approval of CAPLYTA 01/21/21 Intra-Cellular announce publication of results from CAPLYTA trial 12/29/20 Intra-Cellular announces initiation of clinical trials for ITI-LLAI ITCI Intra-Cellular $31.68 / +0.17 (+0.54%) 12/29/20 Cantor Fitzgerald Intra-Cellular price target raised to $54 from $53 at Cantor Fitzgerald 12/15/20 Fly Intel: Top five analyst initiations 12/15/20 BofA Intra-Cellular initiated with a Buy at BofA 12/10/20 Fly Intel: Top five analyst initiations ITCI Intra-Cellular $31.68 / +0.17 (+0.54%) 02/25/21 Intra-Cellular reports Q4 EPS (76c), consensus (85c) 11/09/20 Intra-Cellular reports Q3 EPS (79c), consensus ($1.00) 11 Sep

Earnings	United Airlines sees Q1 revenue $3.2B, consensus $3.29B » 07:39 04/12/21 04/12 07:39 04/12/21 07:39 UAL United Airlines $58.43 / -0.99 (-1.67%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options UAL United Airlines $58.43 / -0.99 (-1.67%) 04/06/21 XpresSpa signs contract for XpresCheck COVID-19 facility at San Fransico Airport 04/06/21 United Airlines sets diversity goal for pilot training academy 04/05/21 United Airlines: Issue with website, app may prevent customers from purchases 04/05/21 CDC issues updated guidance on travel for fully vaccinated people UAL United Airlines $58.43 / -0.99 (-1.67%) 04/06/21 Fly Intel: Top five analyst upgrades 04/06/21 Morgan Stanley Morgan Stanley sees further airline upside, upgrades United and Alaska Air 04/06/21 Morgan Stanley United Airlines upgraded to Equal Weight from Underweight at Morgan Stanley 03/30/21 Jefferies United Airlines price target raised to $60 from $55 at Jefferies UAL United Airlines $58.43 / -0.99 (-1.67%) 01/20/21 United Airlines ended 2020 with $19.7B in available liquidity 01/20/21 United sees Q1 operating revenue down 65%-70%, consensus $4.06B 01/20/21 United Airlines reports Q4 adjusted EPS ($7.00), consensus ($6.60) 01/20/21 Notable companies reporting after market close 22 Apr UAL United Airlines $58.43 / -0.99 (-1.67%) 04/01/21 United Airlines to hire hundreds of pilots amid travel recovery, CNBC say 03/29/21 CDC chief warns of 'impending doom' amid rise in travel, AP reports 03/18/21 Biden administration looks to ease travel restrictions in mid-May, CNBC says 03/03/21 American, United to give J&J COVID-19 vaccine to Chicago workers, Reuters says UAL United Airlines $58.43 / -0.99 (-1.67%) 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 02/22/21 Airbnb, Snap upgrades among today's top calls on Wall Street 02/22/21 Fly Intel: Pre-market Movers 04/20/21 United Airlines - UAL UAL United Airlines $58.43 / -0.99 (-1.67%) 03/17/21 United Continental call volume above normal and directionally bullish 03/15/21 Early notable gainers among liquid option names on March 15th 03/03/21 United Continental call volume above normal and directionally bullish 02/25/21 Unusually active option classes on open February 25th
Recommendations	Mohawk Industries price target raised to $235 from $200 at Raymond James » 07:38 04/12/21 04/12 07:38 04/12/21 07:38 MHK Mohawk Industries $202.93 / +4.795 (+2.42%) Raymond James analyst Sam… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options MHK Mohawk Industries $202.93 / +4.795 (+2.42%) 03/08/21 Mohawk Industries Thiers sells almost $930K in company shares 02/12/21 Mohawk doesn't see commercial business rebounding to prior levels this year 02/12/21 Mohawk: Commercial business has improved from bottom, but remains depressed 02/10/21 Mohawk Industries names James F. Brunk CFO MHK Mohawk Industries $202.93 / +4.795 (+2.42%) 04/07/21 JPMorgan JPMorgan lays out long and short homebuilding ideas into earnings 03/17/21 Wolfe Research Mohawk Industries initiated with a Peer Perform at Wolfe Research 03/16/21 Wolfe Research Mohawk Industries initiated with a Peer Perform at Wolfe Research 02/18/21 Fly Intel: Top five analyst upgrades MHK Mohawk Industries $202.93 / +4.795 (+2.42%) 02/11/21 Mohawk Industries sees Q1 adjusted EPS $2.69-$2.79, consensus $2.11 02/11/21 Mohawk Industries reports Q4 adjusted EPS $3.54, consensus $2.87 10/29/20 Mohawk sees Q4 EPS $2.75-$2.87, consensus $1.99 10/29/20 Mohawk reports Q3 adjusted EPS $3.26, consensus $2.14 MHK Mohawk Industries $202.93 / +4.795 (+2.42%) 10/29/20 Fly Intel: After-Hours Movers 04/30/21 Mohawk Industries - MHK 05/20/21 Mohawk Industries, Inc. MHK Mohawk Industries $202.93 / +4.795 (+2.42%) 02/12/21 Early notable gainers among liquid option names on February 12th 11/02/20 Early notable gainers among liquid option names on November 2nd 10/30/20 Early notable gainers among liquid option names on October 30th
Recommendations	Medavail price target raised to $20 from $18 at Cowen » 07:38 04/12/21 04/12 07:38 04/12/21 07:38 MDVL Medavail $13.04 / -0.06 (-0.46%) Cowen analyst Charles… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research On The Fly MDVL Medavail $13.04 / -0.06 (-0.46%) 04/05/21 Cowen Medavail price target raised to $18 from $17 at Cowen 12/14/20 Lake Street Medavail initiated with a Buy at Lake Street 12/14/20 Cowen Medavail initiated with an Outperform at Cowen MDVL Medavail $13.04 / -0.06 (-0.46%) 12/21/20 Fly Insider: Net 1 UEPS, GrafTech among weeks notable insider trades
Hot Stocks	Watsco completes acquisition of Temperature Equipment Corporation » 07:38 04/12/21 04/12 07:38 04/12/21 07:38 WSO Watsco $276.17 / +5.22 (+1.93%) Watsco announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings WSO Watsco $276.17 / +5.22 (+1.93%) 04/01/21 Watsco board declares cash dividend of $1.95 03/16/21 Watsco to acquire Temperature Equipment Corporation, terms not disclosed 02/11/21 Watsco raises dividend 10% to $7.80 WSO Watsco $276.17 / +5.22 (+1.93%) 03/01/21 JPMorgan Watsco upgraded to Neutral from Underweight at JPMorgan 01/15/21 Jefferies Watsco price target raised to $250 from $230 at Jefferies 01/04/21 Vertical Research Watsco upgraded to Hold from Sell at Vertical Research 10/15/20 Stephens Watsco resumed with an Equal Weight at Stephens WSO Watsco $276.17 / +5.22 (+1.93%) 02/11/21 Watsco reports Q4 EPS $1.14, consensus 99c 12/30/20 Watsco reports 2020 annual sales surpass $5B 10/22/20 Watsco reports Q3 EPS $2.76, consensus $2.47
Hot Stocks	CVS Health expands access to COVID-19 vaccines in several states » 07:38 04/12/21 04/12 07:38 04/12/21 07:38 CVS CVS Health $74.03 / +0.25 (+0.34%) In an ongoing effort to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CVS CVS Health $74.03 / +0.25 (+0.34%) 04/05/21 CVS Health: COVID-19 antibody testing available at MinuteClinics across country 04/01/21 CVS Health surpasses 10M COVID-19 vaccine doses administered 03/29/21 CVS Health expands COVID-19 vaccinations in several states 03/16/21 Brookdale Senior Living completes second round of vaccine clinics at communities CVS CVS Health $74.03 / +0.25 (+0.34%) 04/08/21 Gordon Haskett Gordon Haskett highlights Encompass Health's 'interesting' Rhode Island trip 03/17/21 Guggenheim CVS Health downgraded to Neutral at Guggenheim after 34% rally 03/17/21 Fly Intel: Top five analyst downgrades 03/17/21 Guggenheim CVS Health downgraded to Neutral from Buy at Guggenheim CVS CVS Health $74.03 / +0.25 (+0.34%) 02/16/21 CVS Health sees FY21 revenue $276.1B-$280.6B, consensus $278.39B 02/16/21 CVS Health sees FY21 adjusted EPS $7.39-$7.55, consensus $7.54 02/16/21 CVS Health reports Q4 adjusted EPS $1.30, consensus $1.24 11/06/20 CVS Health raises FY20 adj. EPS view to $7.35-$7.45 from $7.14-$7.27 CVS CVS Health $74.03 / +0.25 (+0.34%) 03/23/21 CVS CEO not 'intimidated' by Amazon push into space, Fierce Healthcare says 03/02/21 IPG Mediabrands planning event focused on Black-owned media firms, AdAge says 02/14/21 Walmart COVID vaccine rollout heading to small towns, WSJ reports 02/11/21 CVS, Walmart to decide who gets leftover vaccine doses, WSJ reports CVS CVS Health $74.03 / +0.25 (+0.34%) 03/16/21 Fly Intel: Wall Street's top stories for Tuesday 03/16/21 Fly Intel: Wall Street's top stories at midday 03/16/21 Higher COVID vaccine reimbursement seen as 'windfall' for drug retailers 03/01/21 Ontrak plunges after announcing loss of Aetna contract 05/13/21 CVS Health Corp CVS CVS Health $74.03 / +0.25 (+0.34%) 03/29/21 CVS Health call volume above normal and directionally bullish 02/16/21 Unusually active option classes on open February 16th 01/11/21 CVS Health call volume above normal and directionally bullish 11/17/20 Unusually active option classes on open November 17th

Initiation	Olo initiated with an Outperform at William Blair » 07:37 04/12/21 04/12 07:37 04/12/21 07:37 OLO Olo $28.28 / -0.64 (-2.21%) William Blair analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate Periodicals On The Fly Options OLO Olo $28.28 / -0.64 (-2.21%) 03/31/21 OLO falls -8.9% 03/18/21 OLO falls -9.9% OLO Olo $28.28 / -0.64 (-2.21%) 07:29 Today Truist Truist starts Olo with a Buy, sees sustained 30% or more growth potential 07:20 Today JPMorgan Olo initiated with an Overweight at JPMorgan 06:53 Today Truist Olo initiated with a Buy at Truist 06:20 Today RBC Capital Olo initiated with an Outperform at RBC Capital 17 Mar OLO Olo $28.28 / -0.64 (-2.21%) 03/31/21 DoorDash accuses partner Olo of fraud, FT reports OLO Olo $28.28 / -0.64 (-2.21%) 03/31/21 Fly Intel: Wall Street's top stories at midday 03/31/21 Olo plunges after being accused of fraud by DoorDash 03/20/21 Opening Day: China's Tuya raised $915M in U.S. IPO OLO Olo $28.28 / -0.64 (-2.21%) 04/07/21 new option listings and two option delistings on April 7th
Hot Stocks	Ingersoll-Rand to sell specialty vehicle technologies segment to Platinum Equity » 07:37 04/12/21 04/12 07:37 04/12/21 07:37 IR Ingersoll-Rand $50.59 / +0.255 (+0.51%) Ingersoll Rand has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals Events IR Ingersoll-Rand $50.59 / +0.255 (+0.51%) 02/18/21 Ingersoll Rand selects Google Cloud to accelerate IoT innovation 02/16/21 AIP to acquire majority interest in Ingersoll-Rand's HPS segment 02/16/21 Ingersoll-Rand to sell majority interest in HPS to American Industrial Partners 12/07/20 Ingersoll-Rand to acquire Tuthill Vacuum and Blower Systems for $184M in cash IR Ingersoll-Rand $50.59 / +0.255 (+0.51%) 04/06/21 Barclays Ingersoll-Rand price target raised to $56 from $53 at Barclays 02/24/21 Deutsche Bank Ingersoll-Rand price target raised to $50 from $47 at Deutsche Bank 02/16/21 UBS Ingersoll-Rand's deal to sell HPS interest 'positive,' says UBS 01/15/21 Jefferies Ingersoll-Rand price target raised to $53 from $45 at Jefferies IR Ingersoll-Rand $50.59 / +0.255 (+0.51%) 02/22/21 Ingersoll Rand sees FY21 revenue growth high-single to low-double digits 02/22/21 Ingersoll Rand reports Q4 adjusted EPS 53c, consensus 45c 02/22/21 Notable companies reporting after market close 11/02/20 Ingersoll-Rand reports Q3 adj. EPS 40c, consensus 31c 17 Jun IR Ingersoll-Rand $50.59 / +0.255 (+0.51%) 04/11/21 Ingersoll-Rand nearing $1.7B deal to sell golf cart business, Reuters reports 06/16/21 Ingersoll-Rand Inc
Recommendations	Alibaba price target lowered to $330 from $350 at Raymond James » 07:37 04/12/21 04/12 07:37 04/12/21 07:37 BABA Alibaba $223.35 / -4.9 (-2.15%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BABA Alibaba $223.35 / -4.9 (-2.15%) 04/10/21 Alibaba fined $2.75B by China for antitrust, vows compliance 03/25/21 SEC begins implementing law that could delist foreign companies like Alibaba 02/16/21 Third Point buys Upstart, exits Caesars in Q4 02/03/21 Alibaba announces proposed offering of senior unsecured notes BABA Alibaba $223.35 / -4.9 (-2.15%) 06:41 Today Mizuho Alibaba antitrust ruling 'removes overhang,' says Mizuho 06:37 Today Citi Alibaba fine could help lift 'overhang' on shares, says Citi 06:36 Today KeyBanc Alibaba price target lowered to $305 from $315 at KeyBanc 04/09/21 Benchmark Alibaba price target lowered to $310 from $315 at Benchmark BABA Alibaba $223.35 / -4.9 (-2.15%) 02/02/21 Alibaba reports Q3 EPS $3.38, consensus $3.25 02/01/21 Notable companies reporting before tomorrow's open 02/01/21 Notable companies reporting before tomorrow's open 11/05/20 Alibaba reports Q2 adjusted EPS $2.65, consensus $2.11 BABA Alibaba $223.35 / -4.9 (-2.15%) 06:18 Today Tencent Music, Meituan concerned after Alibaba's $2.8B fine, FT reports 03/29/21 Energy Monster ownership dispute ahead of U.S. listing, Reuters reports 03/25/21 Ant Group to demand larger fees to rebuild valuation, FT reports 03/23/21 Tencent makes a push for growth, amid China push-back, Bloomberg says BABA Alibaba $223.35 / -4.9 (-2.15%) 03/07/21 Opening Day: InnovAge rises, Oscar Health slips on first trading day 02/28/21 Opening Day: Coinbase files to go public 02/21/21 Opening Day: Podcast app developer Auddia makes public debut 02/14/21 Opening Day: Bumble, Viant soar in market debuts BABA Alibaba $223.35 / -4.9 (-2.15%) 04/07/21 Unusually active option classes on open April 7th 03/10/21 Alibaba call buyer realizes 67% same-day gains 01/08/21 Notable open interest changes for January 8th 12/31/20 Notable open interest changes for December 31st
Hot Stocks	Star Peak Energy Transition, Stem to host fireside chat on combination » 07:37 04/12/21 04/12 07:37 04/12/21 07:37 STPK Star Peak Energy Transition $31.01 / +1.94 (+6.67%) Star Peak Energy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Periodicals Events Options STPK Star Peak Energy Transition $31.01 / +1.94 (+6.67%) 04/08/21 Star Peak Energy Transition rises 12.7% 01/27/21 Star Peak Energy Transition falls -13.3% 01/27/21 Star Peak Energy Transition falls -11.0% 01/12/21 Star Peak Energy Transition rises 13.5% STPK Star Peak Energy Transition $31.01 / +1.94 (+6.67%) 01/11/21 Citron Research puts $100 price target on Star Peak Energy Transition 01/11/21 Citron calls Star Peak Energy' most compelling' alternative energy stock 04/27/21 STAR PEAK ENERGY TRANSITION STPK Star Peak Energy Transition $31.01 / +1.94 (+6.67%) 03/11/21 Star Peak Energy Transition call buyer realizes 53% same-day gains 03/10/21 Star Peak Energy Transition call volume above normal and directionally bullish 02/02/21 Star Peak Energy Transition call volume above normal and directionally bullish 02/01/21 Star Peak Energy Transition call volume above normal and directionally bullish
Recommendations	Revolve Group price target raised to $56 from $45 at Cowen » 07:36 04/12/21 04/12 07:36 04/12/21 07:36 RVLV Revolve Group $51.90 / +0.9 (+1.76%) Cowen analyst Oliver Chen… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options RVLV Revolve Group $51.90 / +0.9 (+1.76%) 03/18/21 Revolve Group jumps 3.5% to $54.40 per share following BofA upgrade to Buy 02/25/21 Revolve Group rises 17.4% 02/25/21 Revolve Group rises 30.9% 02/25/21 Revolve Group rises 20.8% RVLV Revolve Group $51.90 / +0.9 (+1.76%) 04/07/21 Piper Sandler Revolve Group price target raised to $53 from $45 at Piper Sandler 03/24/21 B. Riley Securities Revolve Group price target raised to $58 from $42 at B. Riley Securities 03/18/21 Roth Capital Revolve Group price target raised to $60 from $45 at Roth Capital 03/18/21 BofA Revolve Group upgraded to Buy from Neutral at BofA RVLV Revolve Group $51.90 / +0.9 (+1.76%) 02/24/21 Revolve Group reports Q4 EPS 26c, consensus 11c 11/11/20 Revolve Group reports Q3 EPS 27c, consensus 14c 11/11/20 Notable companies reporting after market close 18 Nov 11 Sep RVLV Revolve Group $51.90 / +0.9 (+1.76%) 11/17/20 TSG Consumer Parners exiting Revolve Group stake in block trade, Bloomberg says RVLV Revolve Group $51.90 / +0.9 (+1.76%) 02/25/21 Fly Intel: Wall Street's top stories for Thursday 02/25/21 Fly Intel: Wall Street's top stories at midday 02/24/21 Fly Intel: After-Hours Movers 11/12/20 Fly Intel: Pre-market Movers RVLV Revolve Group $51.90 / +0.9 (+1.76%) 03/31/21 Unusual call flow in option market yesterday 03/30/21 Bullish ratio call spread vs puts opened in Revolve Group on Cboe 11/11/20 Revolve Group options imply 23.3% move in share price post-earnings